Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

IHS Announces Pricing Of Secondary Public Offering Of Class A Common Stock

RELATED NEWS
Trade IHS now with 
6/21/2012 6:36 PM ET

IHS Inc. (IHS: Quote) announced that an existing stockholder, Conscientia Investment Limited, has priced a secondary public offering of 8.70 million shares of IHS's Class A common stock at $100.00 per share, before deducting the underwriting discount.

The selling stockholder has also granted the underwriter a 30-day option to purchase up to an additional 1,304,347 shares. IHS said that it will not receive any of the proceeds from the sale of shares in the offering.

Click here to receive FREE breaking news email alerts for IHS INC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
While stocks moved sharply lower at the start of trading on Thursday, selling pressure waned not long after the open. The markets have subsequently seen a notable recovery attempt, as some traders look to pick up stocks at reduced levels. The major averages have climbed well off their worst levels but are currently still posting modest losses. In another upbeat sign for the U.S. housing market, the Commerce Department released a report on Thursday showing that new home sales came in well above economist estimates in the month of April. The report showed that new home sales climbed 2.3 percent to a seasonally adjusted annual rate of 454,000 in April from the revised March rate of 444,000. Consumer sentiment in the euro area increased for the sixth consecutive month in May to its strongest level since the middle of last year, preliminary data from the European Commission showed Thursday. The DG ECFIN flash estimate of the consumer confidence indicator for Eurozone came in at -21.9,...
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.